title: Dynamics of adenylate cyclase regulation via heterotrimeric G-proteins.
abstract: A wide variety of G-protein-coupled receptors either activate or inhibit ACs (adenylate cyclases), thereby regulating cellular cAMP levels and consequently inducing proper physiological responses. Stimulatory and inhibitory G-proteins interact directly with ACs, whereas G(q)-coupled receptors exert their effects primarily via Ca2+. Using the FRET-based cAMP sensor Epac1 (exchange protein directly activated by cAMP 1)-cAMPS (adenosine 3',5'-cyclic monophosphorothioate), we studied cAMP levels in single living VSMCs (vascular smooth muscle cells) or HUVECs (human umbilical vein endothelial cells) with subsecond temporal resolution. Stimulation of purinergic (VSMCs) or thrombin (HUVECs) receptors rapidly decreased cAMP levels in the presence of the β-adrenergic agonist isoprenaline via a rise in Ca2+ and subsequent inhibition of AC5 and AC6. Specifically in HUVECs, we observed that, in the continuous presence of thrombin, cAMP levels climbed slowly after the initial decline with a delay of a little less than 1 min. The underlying mechanism includes phospholipase A2 activity and cyclo-oxygenase-mediated synthesis of prostaglandins. We studied further the dynamics of the inhibition of ACs via G(i)-proteins utilizing FRET imaging to resolve interactions between fluorescently labelled G(i)-proteins and AC5. FRET between Gα(i1) and AC5 developed at much lower concentration of agonist compared with the overall G(i)-protein activity. We found the dissociation of Gα(i1) subunits and AC5 to occur slower than the G(i)-protein deactivation. This led us to the conclusion that AC5, by binding active Gα(i1), interferes with G-protein deactivation and reassembly and thereby might sensitize its own regulation.
authors.affiliation: *Department of Pharmacology and Clinical Pharmacy, University of Marburg, Karl-von-Frisch-Strasse 1, 35032 Marburg, Germany.
authors.forename: Markus
authors.initials: M
authors.lastname: Milde
authors.affiliation: *Department of Pharmacology and Clinical Pharmacy, University of Marburg, Karl-von-Frisch-Strasse 1, 35032 Marburg, Germany.
authors.forename: Ruth C
authors.initials: RC
authors.lastname: Werthmann
authors.affiliation: *Department of Pharmacology and Clinical Pharmacy, University of Marburg, Karl-von-Frisch-Strasse 1, 35032 Marburg, Germany.
authors.forename: Kathrin
authors.initials: K
authors.lastname: von Hayn
authors.affiliation: *Department of Pharmacology and Clinical Pharmacy, University of Marburg, Karl-von-Frisch-Strasse 1, 35032 Marburg, Germany.
authors.forename: Moritz
authors.initials: M
authors.lastname: Bünemann
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D019204:GTP-Binding Proteins / Q000378:metabolism*; D061307:Human Umbilical Vein Endothelial Cells / Q000378:metabolism; D006801:Humans; D032389:Myocytes, Smooth Muscle / Q000378:metabolism
chemical_list: D000242:Cyclic AMP; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; C121100:adenylyl cyclase 6; C419510:adenylyl cyclase type V